human-immunodeficiency-virus

Documents about human-immunodeficiency-virus

• HCV/HIV Coinfection: Antiviral Therapy and Fibrosis#915202ClinicalTrials.gov
• ICVAX as a HIV Therapeutic DNA Vaccine#143663ClinicalTrials.gov
• Human Immunodeficiency Virus (HIV)#339164Southampton
• Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)#885401ClinicalTrials.gov
• HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong#28427ClinicalTrials.gov
• Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)#853762ClinicalTrials.gov
• Surveillance for human immunodeficiency virus/acquired immunodeficiency syndrome for countries in transition#220414Figshare
• Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients#915918ClinicalTrials.gov
• An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study#842673ClinicalTrials.gov
• Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults#871319ClinicalTrials.gov
• PRO 140 for Human Immunodeficiency Virus#1008969ClinicalTrials.gov
• A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)#838597ClinicalTrials.gov
• The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo#850096ClinicalTrials.gov
• HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy#831606ClinicalTrials.gov
• PRO 140 for Human Immunodeficiency Virus Infection#890829ClinicalTrials.gov
• Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older#891936ClinicalTrials.gov
• Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults#1007759ClinicalTrials.gov
• Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women#848427ClinicalTrials.gov
• A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children#887036ClinicalTrials.gov
• A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435#908630ClinicalTrials.gov
• Alcohol Monitor Validation#1008746ClinicalTrials.gov
• Food Effect Study With BMS-955176#1009654ClinicalTrials.gov
• Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men#826954ClinicalTrials.gov
• Relaxation Response With Acupuncture for HIV Patients#980798ClinicalTrials.gov
• GSK1349572 Relative Bioavailability Study#874734ClinicalTrials.gov
• Computer-Assisted Tailored Cue-card Health [CATCH] Study#992448ClinicalTrials.gov
• A Clinical Phase 3 Trial of VLA1553 in Adult Participants with Human Immunodeficiency Virus (HIV)#435785ClinicalTrials.gov
• Reality Check: An HIV Risk Reduction Serial Drama#873507ClinicalTrials.gov
• Contributions of the gp120 Variable Loops to Envelope Glycoprotein Trimer Stability in Primate Lentiviruses#995699DigitalCommons@University of Nebraska
• Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects#234401ClinicalTrials.gov
• Maraviroc and NeuroAIDS Pathogenesis#857069ClinicalTrials.gov
• 18 U.S.C. § 4014 — Testing for human immunodeficiency virus#573235US Code (LII)
• The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta#968103ClinicalTrials.gov
• Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis#805928ClinicalTrials.gov
• Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus#853854ClinicalTrials.gov
• Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women#148572ClinicalTrials.gov
• Observational Study of HIV-associated Neurocognitive Disorder#832410ClinicalTrials.gov
• Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism#854415ClinicalTrials.gov
• Regional Differences in Human Immunodeficiency Virus (HIV) Testing#858222ClinicalTrials.gov
• Characteristics and Outcomes of TB and HIV Co-infections#907350ClinicalTrials.gov
• 18 U.S.C. § 1122 — Protection against the human immunodeficiency virus#574082US Code (LII)
• Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)#802473ClinicalTrials.gov
• A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)#830149ClinicalTrials.gov
• Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia#861317ClinicalTrials.gov
• A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study#810555ClinicalTrials.gov
• Accuracy of Portable Colposcopy and HPV Genotypes Among HIV+ Women#875178ClinicalTrials.gov
• The Role of Human Ubc9 During the Human Immunodeficiency Virus Replication Cycle#982847DigitalCommons@University of Nebraska
• Treatment of Oral Warts in HIV+ Patients#841796ClinicalTrials.gov
• Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men#800977ClinicalTrials.gov
• Growth Hormone Dynamics and Cardiac Steatosis in HIV#843237ClinicalTrials.gov